Dissecting Simons' final Renaissance portfolio

After an incredible run, hedge fund legend James Simons calls it quits. Check out what he was targeting.

By John Reese Apr 7, 2010 2:28PM

One of the key parts of my investment approach is finding and learning from strategists who have proven long-term track records, something that can be hard to do in an investment world filled with unproven pundits and talking heads. And, when it comes to a long-term track record, few can match the one compiled by James Simons.


Simons, a quantitative trading pioneer who recently stepped down as chief executive of Renaissance Technologies, the firm he founded nearly 30 years ago, has managed one of the most successful hedge funds in history -- the Medallion fund.

The numbers are the stuff of which legends are made: Medallion has averaged returns of about 45% a year (after fees) since its inception in 1988, according to The Wall Street Journal, which adds that Medallion has had just one down quarter in the past 15 years -- 1999's first quarter, when it dipped a mere 0.5%.

Unlike the gurus upon whom I base my Guru Strategy computer models, Simons hasn't divulged the details of his strategy. But Renaissance's latest SEC filing, for the fourth quarter of 2009, gives an idea of how the firm was positioned when Simons stepped down in January.

While its holdings may well have changed significantly given Renaissance's quick-trading style, I thought it would be interesting to look at which of the firm's biggest recent holdings also get high marks from my Guru Strategies. Several, including Ford (F), Amazon (AMZN), DirecTV (DTV), Genzyme (GENZ), and Oracle (ORCL) didn't meet my models' standards. But several others did. 

Here's a look at some of the stocks that Renaissance held at the end of 2009 that do get approval from one or more of my models:


Express Scripts (ESRX): Based in St. Louis, this pharmacy benefits manager ($28 billion market cap) handles more than a million prescriptions a day through its retail and home delivery services. As of the end of 2009, Renaissance owned close to $90 million worth of the stock, which may well benefit from the new healthcare bill.


Currently, the approach I base on another top quantitative strategist, James O'Shaughnessy, likes ESRX. One reason is that Express has upped earnings per share in each of the past five years. (In fact, it has done so in every year of the past decade.)


O'Shaughnessy also looked for a key pair of qualities when assessing growth stocks: a high relative strength, which allows you to find stocks that are being embraced by the market, and a low price/sales ratio, which makes sure you're not paying too much for those good growth plays. Express has a solid relative strength of 77 and a strong 1.14 P/S ratio, both of which earn this model's approval.


Comcast Corporation (CMCSA): This Philadelphia-based firm is the U.S.'s largest provider of cable services, with 23.6 million cable customers, 15.9 million high-speed Internet customers, and 7.6 million digital phone customers. Renaissance owned close to $250 million worth of a couple different classes of Comcast shares as of the end of 2009, and my Peter Lynch approach is currently high on the firm's Nasdaq-listed common stock. 


Comcast ($53 billion market cap) is a "fast-grower" -- Lynch's favorite type of investment -- according to this approach, thanks to its impressive 35.5% long-term EPS growth rate. (I use an average of the three-, four-, and five-year EPS figures to determine a long-term rate.) Lynch famously used the P/E/Growth ratio to find bargain-priced growth stocks, and when we divide Comcast's 14.93 price/earnings ratio by that long-term growth rate, we get a P/E/G of 0.42. That falls into this model's best-case category (below 0.5). 


Another reason this approach likes Comcast: The firm's 68% debt/equity ratio comes in under the model's 80% upper limit, showing that Comcast appears to be on solid financial footing.


Becton, Dickinson and Company (BDX): Renaissance owned more than $100 million worth of shares of this New Jersey-based firm, which makes a variety of drug delivery and medical diagnostic technologies, at the end of last year. Becton ($18 billion market cap) is also a favorite of Warren Buffett, whose Berkshire Hathaway owns a chunk of its shares -- and a favorite of my Buffett-based model, which became keen on the stock shortly before Berkshire picked it up.


My Buffett-inspired model looks for firms that have consistently upped EPS over the past decade, have manageable debt, and have high returns on equity over the long haul. Becton has increased EPS in each year of the past decade, could pay off its $1.5 billion in debt in a little over a year given its $1.2 billion in annual earnings, and has produced an average annual ROE of almost 20% over the past 10 years, all of which earn high marks from this model.


My Lynch model is also high on Becton, which it considers a "stalwart", the kind of big, steady, defensive firm Lynch liked. My model likes Becton's 16.2% long-term growth rate, 0.88 yield-adjusted P/E/G, and solid 32% debt/equity ratio.


Intel Corporation (INTC): This chip-making giant ($124 billion market cap) has taken in more than $35 billion in sales over the past year. Renaissance owned more than $108 million worth of the California-based firm's shares at the end of 2009, and the stock is now a favorite of my O'Shaughnessy-based value model.


O'Shaughnessy targeted large firms with solid cash flows and strong yields when looking for value plays. Intel's size, $1.71 in cash flow per share (more than twice the market mean of $0.85), and 2.8% yield all fit the bill right now.


Disclosure: I’m long ESRX, BDX, INTC, F, and AMZN.


John Reese is founder and CEO of Validea.com, a premium investment research site, and Validea Capital Management, a separate account advisory firm. He is author of the new investing book, "The Guru Investor: How to Beat the Market Using History's Best Investment Strategies".






Please help us to maintain a healthy and vibrant community by reporting any illegal or inappropriate behavior. If you believe a message violates theCode of Conductplease use this form to notify the moderators. They will investigate your report and take appropriate action. If necessary, they report all illegal activity to the proper authorities.
100 character limit
Are you sure you want to delete this comment?


Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.


StockScouter rates stocks from 1 to 10, with 10 being the best, using a system of advanced mathematics to determine a stock's expected risk and return. Ratings are displayed on a bell curve, meaning there will be fewer ratings of 1 and 10 and far more of 4 through 7.

123 rated 1
262 rated 2
480 rated 3
651 rated 4
649 rated 5
629 rated 6
616 rated 7
496 rated 8
346 rated 9
111 rated 10

Top Picks

TAT&T Inc9



Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.

Contributors include professional investors and journalists affiliated with MSN Money.

Follow us on Twitter @topstocksmsn.